Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dallas Heart Group is a leading cardiovascular medicine practice based in North Texas, providing comprehensive diagnostic, preventive, and treatment services for heart and vascular diseases. The group specializes in various sub-disciplines, including interventional cardiology, electrophysiology, and nuclear cardiology. In 2022, the practice was acquired by US Heart & Vascular, a physician-led management services organization. Beyond clinical care, Dallas Heart Group is actively involved in clinical research, participating in numerous phase 2 and phase 3 trials for cardiovascular therapeutics and medical devices. The organization operates multiple locations across the Dallas-Fort Worth metroplex, serving a large and diverse patient population.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dallas Heart Group.